Functional Analysis of CDKp110 Protein Kinase
Functional Analysis of CDKp110 Protein Kinase
批准号:
7988968
负责人:
JILL M LAHTI
金额:
$11.47万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-12-17 至 2011-03-31
关键词:
Active SitesAmino Acid MotifsBiological AssayCell CycleCell divisionCellsChromatinComplexCyclin-Dependent KinasesCyclinsDefectDevelopmentEmbryoEmbryonic DevelopmentEventExhibitsGenesGenetic TranscriptionHistone H3In VitroKnock-outKnockout MiceLaboratoriesLinkMitosisMusPhenotypePhosphorylationPhosphotransferasesPhysical condensationPlayPrincipal InvestigatorProtein IsoformsProtein KinaseProteinsRNA BindingRNA Polymerase IIRNA ProcessingRNA SplicingRoleSpliceosomesStagingStaining methodStainsTestingTranscriptional Elongation FactorsTranscriptional RegulationWorkbaseblastocystcasein kinase IIdesignin vivoknockout genemRNA Precursornovelprogramsprotein functionresearch studytheoriestranscription factor TFIIFtumor
中文摘要
描述(申请人提供):细胞分裂蛋白(CDK)具有不同的功能,其中大多数与细胞分裂和/或转录的控制密切相关。我们的实验室发现了一个新的CDK亚家族,CDK11蛋白激酶,以前被称为PITSLRE激酶。细胞周期蛋白L1和最近的细胞周期蛋白L2是CDK 11亚型的调控伙伴。我们确定CDK11p110亚型是RNA聚合酶II(RNAP II)复合体的一个组成部分,这与它通过与新的RNA结合基序蛋白RBM16相互作用而影响转录延伸和潜在的转录起始的能力是一致的。CDK11p110也存在于剪接体复合体中,并在前mRNA剪接事件中发挥作用。这一功能在CDK中是独一无二的,富含RS的通用前mRNA剪接因子RNPS1和9G8被认为是真正的相互作用因子。CDK11p110/p58缺失的小鼠胚胎不能发育到E3.5以上,这表明CDK11p110和/或CDK11p58的激酶功能对于囊胚后胚胎的发育是必不可少的。综上所述,这些研究有力地表明,CDK11p110激酶的功能对于细胞周期中正常的转录调节和RNA处理是必不可少的。然而,我们不知道CDK11p110激酶功能如何协调调节RNAP II/剪接体复合体的组成/功能。根据我们对CDK11p110/p58基因敲除的研究,CDK11p110/p58对于正常的胚胎发育是必不可少的,与其他CDKs不同(即CDKs-1和CDKs-3除外),我们假设这些基因敲除小鼠的部分表型是由于CDK11p110的缺失,并且该蛋白的功能是发育所必需的。为了验证这些假说,我们建议通过实验来回答以下具体目标:(1)CDK11p110与RNAPII和剪接体复合体中的因子结合和/或磷酸化的功能意义是什么?CDK11p110在协调剪接和转录中起关键作用吗?(2)CK11p110亚型在发育中的胚胎中有什么功能?如果只切除CDK11p110或CDK11,是否有可能获得可存活的胚胎?如果是这样的话,这些小鼠更容易患上肿瘤还是发育缺陷?
英文摘要
DESCRIPTION (provided by applicant): The cell division kinases (CDKs) have diverse functions, most of which are prominently linked to the control of cells division and/or transcription. Our laboratory identified a novel CDK subfamily, the CDK11 protein kinases previously known as the PITSLRE kinases. Cyclin L1 and, more recently, cyclin L2, are regulatory partners of the CDK 11 isoforms. We determined that the CDK11p110 isoform is a component of RNA polymerase II (RNAP II) complexes, consistent with its demonstrated ability to influence transcriptional elongation and potentially transcriptional initiation via interaction with a novel RNA-binding motif protein RBM16. CDK11p110 is also found in spliceosome complexes and has a role in pre-mRNA splicing events. This function is unique among the CDKs, with the RS-rich general pre-mRNA splicing factors RNPS1 and 9G8 identified as bona fide interactors. CDK11p110/p58-null mouse embryos fail to develop past E3.5, indicating that CDK11p110 and/or CDK11p58 kinase function is essential for post-blastocyst embryonic development. Taken together, these studies strongly suggest that CDK11p110 kinase function is essential for normal regulation of transcription and RNA processing during the cell cycle. However, we do not know how CDK11p110 kinase function might coordinately regulate the composition/function of RNAP II/spliceosome complexes. Based upon our cdc2l gene knockout studies CDK11p110/p58 is essential for normal embryonic development, unlike other CDKs (i.e., with the exception of CDKs-1 and -3), we hypothesize that a portion of the phenotype of these knockout mice is due to the absence of CDK11p110 and that the functions of the protein are required for development. To test these hypotheses we propose experiments to answer the following specific aims: (1) What is the functional significance of CDK11p110 kinase association with and/or phosphorylation of factors in RNAPII and spliceosome complexes? Does CDK11p110 play a crucial role in coordinating splicing and transcription? (2) What is the function of the CK11p110 isoform in the developing embryo? Is it possible to obtain viable embryos if only CDK11p110 or CDK11 is ablated? If so, are these mice more prone to tumors or developmental defects?
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Structure and gene expression of avian cyclin D2.
禽细胞周期蛋白D2的结构和基因表达。
DOI:
10.1016/0378-1119(95)00598-6
发表时间:
1995
期刊:
Gene
影响因子:
3.5
作者:
[Li,H, Grenet,J, Kidd,VJ]
通讯作者:
Kidd,VJ
The gene for mouse p58cdc2L1 (Cdc2l1) protein kinase maps to distal mouse chromosome 4.
小鼠 p58cdc2L1 (Cdc2l1) 蛋白激酶基因定位于小鼠 4 号远端染色体。
DOI:
10.1007/bf00352357
发表时间:
1994
期刊:
Mammalian genome : official journal of the International Mammalian Genome Society
影响因子:
--
作者:
[Mock,BA, Padlan,C, Kozak,CA, Kidd,V]
通讯作者:
Kidd,V
Chromosomal localization of a human cDNA containing a DIDS binding domain and demonstrating high homology to yeast omnipotent suppressor 45.
含有 DIDS 结合域的人类 cDNA 的染色体定位,并证明与酵母全能抑制因子 45 具有高度同源性。
DOI:
10.1007/bf01233452
发表时间:
1992
期刊:
Somatic cell and molecular genetics
影响因子:
--
作者:
[Grenett,HE, Eipers,PG, Kidd,VJ, Bounelis,P, Fuller,GM]
通讯作者:
Fuller,GM
DOI:
10.1016/s0021-9258(17)40749-6
发表时间:
1994-06
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[J. Xiang;J. Lahti;J. Grenet;J. Easton;V. Kidd]
通讯作者:
J. Xiang;J. Lahti;J. Grenet;J. Easton;V. Kidd
The PITSLRE protein kinase family.
PITSLRE 蛋白激酶家族。
DOI:
10.1007/978-1-4615-1809-9_27
发表时间:
1995
期刊:
Progress in cell cycle research
影响因子:
--
作者:
[Lahti,JM, Xiang,J, Kidd,VJ]
通讯作者:
Kidd,VJ
共 15 条
Cytogenetics
-
批准号:8738008
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2012
-
负责人:JILL M LAHTI
-
依托单位:
Cytogenetics
-
批准号:7714160
-
项目类别:
-
资助金额:$9.33万
-
财政年份:2008
-
负责人:JILL M LAHTI
-
依托单位:
REGULATION OF CYCLIN C FUNCTION IN TUMORS & NORMAL CELLS
-
批准号:6164228
-
项目类别:
-
资助金额:$10.54万
-
财政年份:1997
-
负责人:JILL M LAHTI
-
依托单位:
REGULATION OF CYCLIN C FUNCTION IN TUMORS & NORMAL CELLS
-
批准号:2668059
-
项目类别:
-
资助金额:$9.75万
-
财政年份:1997
-
负责人:JILL M LAHTI
-
依托单位:
REGULATION OF CYCLIN C FUNCTION IN TUMORS & NORMAL CELLS
-
批准号:6362617
-
项目类别:
-
资助金额:$10.95万
-
财政年份:1997
-
负责人:JILL M LAHTI
-
依托单位:
REGULATION OF CYCLIN C FUNCTION IN TUMORS & NORMAL CELLS
-
批准号:2010643
-
项目类别:
-
资助金额:$9.38万
-
财政年份:1997
-
负责人:JILL M LAHTI
-
依托单位:
REGULATION OF CYCLIN C FUNCTION IN TUMORS & NORMAL CELLS
-
批准号:2882465
-
项目类别:
-
资助金额:$10.14万
-
财政年份:1997
-
负责人:JILL M LAHTI
-
依托单位:
Apoptotic Pathway Defects in Neuroblastoma
-
批准号:6697051
-
项目类别:
-
资助金额:$33.75万
-
财政年份:1995
-
负责人:JILL M LAHTI
-
依托单位:
Apoptotic Pathway Defects in Neuroblastoma
-
批准号:7005695
-
项目类别:
-
资助金额:$32.96万
-
财政年份:1995
-
负责人:JILL M LAHTI
-
依托单位:
Apoptotic Pathway Defects in Neuroblastoma
-
批准号:7822524
-
项目类别:
-
资助金额:$3.36万
-
财政年份:1995
-
负责人:JILL M LAHTI
-
依托单位:
Apoptotic Pathway Defects in Neuroblastoma
-
批准号:7157001
-
项目类别:
-
资助金额:$32.0万
-
财政年份:1995
-
负责人:JILL M LAHTI
-
依托单位:
The Role of Caspase-8 in Neuroblastoma Tumorigenesis
-
批准号:8136704
-
项目类别:
-
资助金额:$38.34万
-
财政年份:1995
-
负责人:JILL M LAHTI
-
依托单位:
Apoptotic Pathway Defects in Neuroblastoma
-
批准号:6835196
-
项目类别:
-
资助金额:$33.75万
-
财政年份:1995
-
负责人:JILL M LAHTI
-
依托单位:
The Role of Caspase-8 in Neuroblastoma Tumorigenesis
-
批准号:7791973
-
项目类别:
-
资助金额:$39.01万
-
财政年份:1995
-
负责人:JILL M LAHTI
-
依托单位:
Functional Analysis of CDKp110 Protein Kinase
-
批准号:7022258
-
项目类别:
-
资助金额:$27.83万
-
财政年份:1991
-
负责人:JILL M LAHTI
-
依托单位:
STRUCTURE/FUNCTION OF PITSLRE KINASES
-
批准号:6636008
-
项目类别:
-
资助金额:$24.5万
-
财政年份:1991
-
负责人:JILL M LAHTI
-
依托单位:
Functional Analysis of CDKp110 Protein Kinase
-
批准号:7212194
-
项目类别:
-
资助金额:$27.02万
-
财政年份:1991
-
负责人:JILL M LAHTI
-
依托单位:
Functional Analysis of CDKp110 Protein Kinase
-
批准号:7390316
-
项目类别:
-
资助金额:$27.02万
-
财政年份:1991
-
负责人:JILL M LAHTI
-
依托单位:
Functional Analysis of CDKp110 Protein Kinase
-
批准号:6922664
-
项目类别:
-
资助金额:$28.5万
-
财政年份:1991
-
负责人:JILL M LAHTI
-
依托单位:
Cytogenetics
-
批准号:8234118
-
项目类别:
-
资助金额:$16.23万
-
财政年份:--
-
负责人:JILL M LAHTI
-
依托单位:
海外基金